OHTAC recommendation: photoselective vaporization for the treatment of benign prostatic hyperplasia
Ontario Health Technology Advisory Committee
Record ID 32014000047
English
Authors' recommendations:
Based on the earlier analysis from the Medical Advisory Secretariat on "Energy Delivery Systems for
Treatment of Benign Prostatic Hyperplasia" and further evidence from the subsequent field evaluation
study, OHTAC makes the following recommendations:
- Photoselective laser vaporization for benign prostatic hyperplasia is an effective, safe, and
cost-effective alternative to transurethral resection of the prostate (TURP) and may be
increasingly preferred over TURP because it can be performed in the outpatient setting, with
less blood loss and a reduced need for hospital admission.
- Appropriate diffusion of this technology will require training programs for urologists to
develop the necessary skills to perform the procedure.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.hqontario.ca/portals/0/Documents/eds/recommendation-pvp-130812-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Prostatic Hyperplasia
- Laser Therapy
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.